The phosphatidylserine market is estimated to be valued at US$ 2.27 Bn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Phosphatidylserine is a type of phospholipid that makes up part of all cells membranes and plays an important role in brain health and cognitive function. It is often used as a dietary supplement to support sports performance, mental processing and memory support. Phosphatidylserine supplements come in capsule or powder form and are commonly used to improve neurological health and reduce stress. Market Dynamics: Phosphatidylserine market is primarily driven by the increasing demand for brain health supplements owing to the growing geriatric population and prevalence of neurodegenerative disorders. According to the World Health Organization, the number of people aged 60 years and older is expected to rise from 900 million to 2 billion between 2015 and 2050. With aging comes an increased risk of cognitive disorders which is prompting more people to consume supplements that support brain function. Furthermore, rising health consciousness among consumers and growing adoption of healthy lifestyles is also fueling the adoption of nutritional supplements for overall well-being. The market is also driven by increasing awareness about the cognitive benefits of phosphatidylserine through extensive research and marketing campaigns by leading players. Several clinical studies have validated the role of phosphatidylserine in reducing stress levels, enhancing mood, memory and learning abilities. SWOT Analysis Strength: Phosphatidylserine improves brain and cognitive functions. It also enhances memory, learning ability and concentration. Phosphatidylserine play an important role in improving mood and reducing depression. It helps in maintaining a healthy cell membrane structure and function. Weakness: Research indicates that Phosphatidylserine supplements may cause side effects such as nausea, diarrhea, and stomach discomfort in some people. Phosphatidylserine are derived from animal sources or soybean which may cause allergy to some people. Opportunity: Increasing prevalence of Alzheimer's disease and dementia related conditions across the globe offers lucrative opportunities for phosphatidylserine market. Growing health awareness among consumer regarding cognitive health benefits of phosphatidylserine supplements further augments the market growth. Threats: Stringent government regulations regarding use of animal or plant sourced ingredients in supplements may hamper the growth of phosphatidylserine market. Also, availability of alternative brain supplement products poses threat to phosphatidylserine market. Key Takeaways Global Phosphatidylserine Market Size is expected to witness high growth, exhibiting CAGR of 6.3% over the forecast period, due to increasing consumer preference for supplements that support mental well-being and cognitive functions. Regional analysis: The North America region currently dominates the phosphatidylserine market owing to growing geriatric population and increasing prevalence of Alzheimer's disease. Asia Pacific is expected to be the fastest growing market for phosphatidylserine driven by rising health consciousness and growing disposable income in developing economies like China and India. Key players: Key players operating in the phosphatidylserine market are Solgar Inc., Nature's Way Products LLC, Wuhan Demekai Biotechnology Co. Ltd., Jarrow Formulas Inc, Lipoid GmbH, Lipogen Products Ltd., Double Wood LLC., Xi'an Sino Herb Bio-Technology Co. Ltd., Xi'an Natural Field Bio-Technique Co. Ltd., N J Chsoyue Pharm Co. Ltd., Swanson Health Products Inc., ECA Healthcare Inc., and IvoVital GmbH.
0 Comments
|
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
April 2024
Categories
All
|